3-Methylquinoxalin-2-ol,
14003-34-0,
3-Methyl-2-quinoxalinol,
2-Hydroxy-3-methylquinoxaline,
3-methylquinoxalin-2(1H)-one,
3-Methyl-1H-quinoxalin-2-one,
2-QUINOXALINOL, 3-METHYL-,
USAF EL-7,
2(1H)-Quinoxalinone, 3-methyl-,
3-Methyl-2(1H)-quinoxalinone,
3-Hydroxy-2-methylquinoxaline,
2-Hydroxy-3-methyl quinoxaline,
EINECS 237-807-4,
NSC 149824,
BMIMNRPAEPIYDN-UHFFFAOYSA-N,
3-methyl-1,2-dihydroquinoxalin-2-one,
WLN: T66 BN ENJ CQ D,
NSC38589,
PubChem15424,
methyldihydroquinoxalinone,
3-Methyl-2-quinoxalone,
3-methyl-quinoxalin-2-ol,
AC1L1B0X,
MLS000778411,
3-methylhydroquinoxalin-2-one,
SCHEMBL536562,
CHEMBL157238,
3-Methyl-2-quinoxalinol, 98%,
CTK4C2045,
2(1H)-Quinoxalinone,3-methyl-,
DTXSID30161219,
HMS2774P17,
ALBB-020076,
CCG-1920,
NSC17798,
ZINC8615434,
BBL005270,
CCG-49309,
MFCD00047567,
NSC-17798,
NSC-38589,
NSC149824,
SBB003967,
STK874234,
STL138586,
AKOS000120338,
AKOS000446145,
MCULE-2369055906,
MF-0223,
NSC-149824,
RP10201,
NCGC00246411-01,
2-Hydroxy-3-methylquinoxaline AldrichCPR,
AJ-57753,
CS-10790,
SMR000415205,
2(1H)-Quinoxalinone, 3-methyl- (8CI),
2-Hydroxy-3-methylquinoxaline, AldrichCPR,
AB0219374,
DB-042505,
LS-143067,
AM20070310,
BB 0241984,
FT-0636995,
R1789,
ST45022914,
10.14272/BMIMNRPAEPIYDN-UHFFFAOYSA-N,
2(1H)-Quinoxalinone, 3-methyl- (8CI)(9CI),
10.14272/BMIMNRPAEPIYDN-UHFFFAOYSA-N.1,
10.14272/BMIMNRPAEPIYDN-UHFFFAOYSA-N.2,
A807616,
doi:10.14272/BMIMNRPAEPIYDN-UHFFFAOYSA-N,
doi:10.14272/BMIMNRPAEPIYDN-UHFFFAOYSA-N.1,
doi:10.14272/BMIMNRPAEPIYDN-UHFFFAOYSA-N.2,
J-512928,
SR-01000638772-1,
F0176-0156,
InChI=1/C9H8N2O/c1-6-9(12)11-8-5-3-2-4-7(8)10-6/h2-5H,1H3,(H,11,12,
8UB,
Cc1nc2ccccc2nc1O,
C9H8N2O,
C9-H8-N2-O,
CID26384,
3-(2-thiophen-2-ylethenyl)-1~{H}-quinoxalin-2-one,